efaproxiral has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donnelly, ET; Kelley, M; Rockwell, S | 1 |
| Ara, G; Buxton, D; Gravelin, LM; Takeuchi, H; Teicher, BA; Wong, JS | 1 |
| Kelley, M; Rockwell, S | 1 |
3 other study(ies) available for efaproxiral and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Survival; Cisplatin; Combined Modality Therapy; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Oxygen; Oxygen Inhalation Therapy; Propionates; Tumor Cells, Cultured | 2004 |
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Topics: Allosteric Regulation; Aniline Compounds; Animals; Antisickling Agents; Bone Marrow Cells; Carcinoma, Lewis Lung; Colony-Forming Units Assay; Combined Modality Therapy; Female; Hemoglobins; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Propionates; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1998 |
RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
Topics: Aniline Compounds; Animals; Antisickling Agents; Bone Marrow Cells; Chemotherapy, Adjuvant; Dose-Response Relationship, Radiation; Female; Hemoglobins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Propionates; Radiation-Sensitizing Agents; Skin; Tumor Cells, Cultured | 1998 |